Aegeus Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 02-07-2024
- Paid Up Capital ₹ 0.10 M
as on 02-07-2024
- Company Age 6 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.17 Cr
as on 02-07-2024
- Revenue -1.77%
(FY 2022)
- Profit -19.81%
(FY 2022)
- Ebitda 10.92%
(FY 2022)
- Net Worth 49.59%
(FY 2022)
- Total Assets -2.62%
(FY 2022)
About Aegeus Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.17 Cr.
Ansul Chadda, Lalit Raut, Nirmal Patle, and Four other members serve as directors at the Company.
- CIN/LLPIN
U74999MH2018PTC308336
- Company No.
308336
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Apr 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Aegeus Pharma?
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lalit Raut  | Director | 28-Mar-2019 | Current |
| Ansul Chadda | Director | 28-Oct-2019 | Current |
| Nirmal Patle | Director | 28-Oct-2019 | Current |
| Parikshit Mahajan | Director | 28-Mar-2019 | Current |
| Ashish Ganjare | Director | 20-Apr-2018 | Current |
| Anantsingh Rajput | Director | 28-Oct-2019 | Current |
Financial Performance and Corporate Structure Insights of Aegeus Pharma.
Aegeus Pharma Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 1.77% decrease. The company also saw a substantial fall in profitability, with a 19.81% decrease in profit. The company's net worth Soared by an impressive increase of 49.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aegeus Pharma?
In 2021, Aegeus Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Aureus Institute Of Medical Sciences Private LimitedActive 7 years 4 monthsAnsul Chadda, Lalit Raut and 5 more are mutual person
Zest Multicare Hospital Private LimitedActive 9 years 6 monthsLalit Raut, Parikshit Mahajan and 3 more are mutual person
- Benefician Health And Wellness FoundationActive 4 years 11 months
Lalit Raut and Ashish Ganjare are mutual person
- Benefician Hospital And Healthcare Private LimitedActive 6 years 1 month
Ashish Ganjare is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 29 Jul 2019 | ₹2.17 Cr | Open |
How Many Employees Work at Aegeus Pharma?
Unlock and access historical data on people associated with Aegeus Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aegeus Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aegeus Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
